A multiplex diagnostic test kit for nucleic acid detection of SARS-CoV-2, influenza A, and influenza B. This kit enables molecular diagnosis of multiple respiratory pathogens in clinical samples.
Manufactured by
Hecin Scientific, Inc.
Guangzhou, Guangdong, China
Guangdong Hecin Scientific, Inc. an in-vitro diagnostics (IVD) company with more than 5,000 m2 factory and P2 biosafety laboratory of respiratory pathogens. Hecin has developed the largest biobank and the most comprehensive range of in-vitro diagnosis products of respiratory pathogens in China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shenzhen Uni-medica Technology Co., Ltd
China · 6 relevant products
Coyote Bioscience Co.,Ltd
China · 12 relevant products
Nanjing Liming Bio-products Co., Ltd.
China · 2 relevant products
58 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 35 relevant matches
Shenzhen Uni-medica Technology Co., Ltd · China
A rapid detection kit for simultaneous qualitative detection of Influenza A, Influenza B, SARS-CoV-2, and Respiratory Syncytial Virus nucleic acids in clinical samples.
Coyote Bioscience Co.,Ltd · China
A diagnostic test kit for the simultaneous detection of SARS-CoV-2 and influenza A and B virus nucleic acids using fluorescence PCR methodology. The kit enables multiplex detection of COVID-19 and influenza in a single assay.
Coyote Bioscience Co.,Ltd · China
A multiplex nucleic acid detection kit for simultaneous identification of SARS-CoV-2 and Type A/B influenza viruses using fluorescent PCR methodology. The kit enables efficient co-screening for COVID-19 and influenza in clinical specimens.
32 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products